CFA
ABBV icon

Collaborative Fund Advisors’s AbbVie ABBV Stock Holding History

Collaborative Fund Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Buy
6,568
+4,035
+159% +$868K 0.96% 23
2026
Q1 		$551K Buy
+2,533
New +$562K 0.34% 84

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Collaborative Fund Advisors's ABBV Position: Q2 2026 in Review

Collaborative Fund Advisors increased its AbbVie (ABBV) stake by 159% in Q2 2026, buying an estimated $868K and bringing the position to 6,568 shares worth $1.65M. The position accounts for 0.96% of the portfolio, ranked #23.

Collaborative Fund Advisors first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Collaborative Fund Advisors held 6,568 shares of AbbVie worth $1.65M as of Q2 2026.
  • Collaborative Fund Advisors bought 4,035 AbbVie shares in Q2 2026, an estimated $868K.
  • AbbVie made up 0.96% of Collaborative Fund Advisors's portfolio in Q2 2026, its #23 holding.
  • Collaborative Fund Advisors first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
  • 4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Collaborative Fund Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.